202
Participants
Start Date
December 17, 2020
Primary Completion Date
February 27, 2026
Study Completion Date
February 27, 2026
N-acetyl cysteine
600 mg N-acetylcysteine (NAC) oral tablets three times daily for 24 months.
Placebo
Matching oral placebo tablet three times daily for 24 months.
Weill Cornell Medicine, New York
University of Rochester, Rochester
Temple University, Philadelphia
University of Virginia, Charlottesville
Medical University of South Carolina, Charleston
Piedmont Healthcare, Austell
Lisa Lancaster, Nashville
Ohio State University, Columbus
Indiana University, Indianapolis
University of Michigan, Ann Arbor
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Loyola University, Maywood
University of Chicago, Chicago
University of Kansas Medical Center, Kansas City
Tulane University, New Orleans
University of Texas Southwestern, Dallas
University of Texas Health San Antonio, San Antonio
University of Colorado, Aurora
University of Utah Health, Salt Lake City
University of Arizona, Tucson
University of Southern California, Los Angeles
Stanford University, Stanford
University of Washington, Seattle
Massachusetts General Hospital, Boston
University of Virginia
OTHER
University of Michigan
OTHER
Pulmonary Fibrosis Foundation
OTHER
University of Washington
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Three Lakes Foundation
UNKNOWN
Fernando J Martinez
OTHER